戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 atment, and contamination with Mycobacterium avium.
2 ed in B. pertussis, B. parapertussis, and B. avium.
3  to yet distinguishable from M. avium subsp. avium.
4 , TNF-alpha has a protective role against M. avium.
5 by reinfection with a separate isolate of M. avium.
6  from the 448 included patients, 54% were M. avium, 18% were M. intracellulare, and 28% were M. chima
7 cobacterium mucogenicum (52%), Mycobacterium avium (30%), and Mycobacterium gordonae (25%).
8 nd to be identical to S(1)-RNase from Prunus avium, a species that does not interbreed with P. tenell
9 ide polymorphisms (SNPs), suggesting that M. avium accumulates mutations at higher rates during persi
10 atients whose isolates were identified as M. avium (adjusted odds ratio [AOR], 2.14; 95% confidence i
11                                           B. avium agglutinates guinea pig erythrocytes via an unknow
12                  The region is unique for M. avium and is not present in M. tuberculosis or M. paratu
13 intracellulare (n = 57; 35.8%), and mixed M. avium and M. intracellulare (n = 2; 1.3%).
14 um-M. intracellulare complex strains into M. avium and M. intracellulare may provide a tool to better
15  probe but negative with species-specific M. avium and M. intracellulare probes), and 3 (7%) were M.
16 mycobacterial activity against Mycobacterium avium and Mycobacterium bovis Bacille Calmette-Guerin (B
17  cattle infected with either M. avium subsp. avium and Mycobacterium bovis were exposed to the array
18 , a major surface component of Mycobacterium avium and other non-tuberculosis mycobacteria, are ligan
19 is growing evidence that the incidence of M. avium and related nontuberculous species is increasing i
20 e, polymorphic SNPs for sweet cherry and the avium and the fruticosa subgenomes of sour cherry, respe
21 aused by Pneumocystis carinii, Mycobacterium avium, and Campylobacter coli that required euthanasia b
22 , E. casseliflavus, E. faecium, E. hirae, E. avium, and E. durans, respectively.
23        Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa are opportunistic prem
24 ogens (Legionella pneumophila, Mycobacterium avium, and Pseudomonas aeruginosa), broader genera (Legi
25 dy we isolated different GPL species from M. avium, and using mass spectrometry and NMR analyses, cha
26      Patients treated for infections with M. avium (AOR, 5.64; 95% CI, 1.51-21.10) and M. chimaera (A
27 ia (NTM), some of which-namely Mycobacterium avium-are important opportunistic pathogens.
28 (-/-) mice are as resistant to Mycobacterium avium as Rag2(-/-) mice, whereas Rag2(-/-) mice lacking
29 nfection with a highly virulent strain of M. avium, but not with a low-virulence strain, led to a pro
30 Mycobacterium tuberculosis and Mycobacterium avium can complement lpqM donor mutants, suggesting that
31                                   Bordetella avium causes bordetellosis in birds, a disease similar t
32 hat in self-incompatible species, such as P. avium, close neighbours may be pollinated by very differ
33 obacterium abscessus (34%) and Mycobacterium avium complex (83%) were the most common nontuberculous
34                    M. abscessus (34%) and M. avium complex (83%) were the most commonly isolated nont
35 case of recurrent disseminated Mycobacterium avium complex (DMAC) disease with anti-gamma interferon
36 64%) were culture-positive for Mycobacterium avium complex (MAC) and 69 (36%) for M. abscessus.
37 A gene target for rapid identification of M. avium complex (MAC) and a region of the heat shock prote
38                 Members of the Mycobacterium avium complex (MAC) are characterized as nontuberculosis
39 drug used for the treatment of Mycobacterium avium complex (MAC) disease, but standard laboratory gui
40 pportunistic infections due to Mycobacterium avium complex (MAC) have been less common since the intr
41           Persistent growth of Mycobacterium avium complex (MAC) in the lungs indicates continuous in
42                            The Mycobacterium avium complex (MAC) is an important group of opportunist
43         Lung disease caused by Mycobacterium avium complex (MAC) is increasing in prevalence.
44 r sources for 36 patients with Mycobacterium avium complex (MAC) lung disease were evaluated.
45 uate relapses in patients with Mycobacterium avium complex (MAC) lung disease, but the "gold standard
46 avitary nodular bronchiectatic Mycobacterium avium complex (MAC) lung disease, supporting data are li
47           Organisms within the Mycobacterium avium complex (MAC) may have differential virulence.
48 ne probe assay for identifying Mycobacterium avium complex (MAC) species and Mycobacterium abscessus
49         Total mycobacteria and Mycobacterium avium complex (MAC) were quantified by qPCR targeting, r
50                                Mycobacterium avium complex (MAC) were the dominant species isolated f
51                                Mycobacterium avium complex (MAC) within macrophages undergoes a pheno
52 culous mycobacteria (NTM), and Mycobacterium avium complex (MAC), however, were widespread.
53 bacterium tuberculosis complex (MTC), the M. avium complex (MAC), the M. chelonae-M. abscessus group
54 lmonary disease are members of Mycobacterium avium complex (MAC).
55 cies, including members of the Mycobacterium avium complex (MAVC).
56 r syndrome, monocytopenia with Mycobacterium avium complex (MonoMAC), and MDS.
57  nontuberculous mycobacterial (Mycobacterium avium complex [MAC] or Mycobacterium abscessus) disease.
58        One hundred isolates of Mycobacterium avium complex and eight M. simiae isolates had tedizolid
59 These results suggest that members of the M. avium complex have a novel mechanism for activating cyto
60 V-infected patients, unmasking Mycobacterium avium complex infection after starting antiretroviral th
61 ycobacterium tuberculosis, M. leprae, and M. avium complex infections.
62  for susceptibility testing of Mycobacterium avium complex isolates against clarithromycin.
63 eem not to be risk factors for Mycobacterium avium complex lung disease in HIV-negative adults, but p
64                                Mycobacterium avium complex lung disease is an increasingly common and
65 oing standard macrolide-based therapy for M. avium complex lung disease were monitored at standard fr
66  candidiasis, and disseminated Mycobacterium avium complex or Mycobacterium kansasii infection.
67  Ten of 639 MGIT cultures grew Mycobacterium avium complex or Mycobacterium kansasii, half of which w
68 y treated for tuberculosis and Mycobacterium avium complex predominated (27.7% [95% CI: 27.2-28.9%]).
69                                Mycobacterium avium complex was concomitantly isolated in two cases, a
70  of positive cultures were for Mycobacterium avium complex, although this ranged by state, from 29% i
71 r Cryptococcus, 10% (1/10) for Mycobacterium avium complex, and 4% (3/72) for PCP.
72 acterium tuberculosis complex, Mycobacterium avium complex, and Mycobacterium spp. directly from clin
73 t common NTM pathogens such as Mycobacterium avium complex, Mycobacterium kansasii, and Mycobacterium
74 10.8%); 45.7% of isolates were Mycobacterium avium complex.
75 hold water/biofilm isolates of Mycobacterium avium could be matched by DNA fingerprinting.
76 this important receptor, and suggest that M. avium could potentially modify its GPL structure to limi
77 ly endemic varieties of sweet cherry (Prunus avium): cv. 'Spatbraune von Purbach', cv. 'Early Rivers'
78  Antiserum to HagB, but not HagA, blocked B. avium erythrocyte agglutination and explanted turkey tra
79 is activation is regulated in part by the M. avium fadD2 gene.
80 ate microbial identification of Enterococcus avium from metagenomic samples with FDA-ARGOS reference
81 eumophila from recolonizing biofilms, but M. avium gene numbers increased by 0.14-0.76 logs in the bu
82                               To identify M. avium genes and host cell pathways involved in the bacte
83 with 58% of G+C content versus 69% in the M. avium genome.
84 ing, respectively, 11.0 and 2.4 Mb of the P. avium genome.
85 m a nonTB species of the genus Mycobacterium avium grown in liquid culture media.
86 ed Rag2(-/-)gammac(-/-) animals increased M. avium growth in the liver.
87 cies Mycobacterium marinum and Mycobacterium avium harboring insertions in the orthologous gene whose
88                              Studies with M. avium have shown that cytoskeletal rearrangement via act
89 y revealed the rapid genetic evolution of M. avium in chronically infected patients, accompanied by c
90 tion induced by infection with Mycobacterium avium in human primary macrophages.
91 uted to decreased intracellular growth of M. avium in primary human macrophages that was reconstitute
92 RNA-mediated knockdown of Keap1 increased M. avium-induced expression of inflammatory cytokines and t
93  the control of inflammatory signaling in M. avium-infected human primary macrophages.
94             Here, we show that Mycobacterium avium-infected T cell-deficient mice injected with CD4 T
95 of experimentally inducible IRIS in which M. avium-infected T cell-deficient mice undergo a fatal inf
96 N-gamma and can confer protection against M. avium infection in immunocompromised mice.
97 e used a model of disseminated Mycobacterium avium infection in mice to investigate the mechanisms of
98  years of age or older were more prone to M. avium infection than younger women or men of all ages we
99 term repopulating HSCs proliferate during M. avium infection, and that this response requires interfe
100 sing an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-te
101       Using the mouse model of Mycobacterium avium infection, we show in this study that the producti
102 re required for granuloma assembly during M. avium infections in mice.
103                                           M. avium infects macrophages and actively interfere with th
104 ecies do cause human infections, and that M. avium infects mainly postmenopausal women.
105 d be facilitated growth of pathogens like M. avium inside macrophages.
106 15.8%), M triplex in 1 patient (5.3%), and M avium intracellulare in 1 patient (5.3%).
107                                Mycobacterium avium is a major opportunistic pathogen in HIV-positive
108                                Mycobacterium avium is abundant in the environment.
109 o characterize the genomic changes within M. avium isolates collected from single patients over time
110                                           M. avium isolates were significantly more likely to be asso
111 xidant capacities of 24 sweet cherry (Prunus avium L.) cultivars grown on the mountainsides of the Et
112                 Fifteen sweet cherry (Prunus avium L.) old cultivars grown in the Czech Republic were
113                         Sweet cherry (Prunus avium L.) trees are both economically important fruit cr
114  market driven trait in sweet cherry (Prunus avium L.) where the desirable increase in fruit firmness
115 age/shipping quality of sweet cherry (Prunus avium L.), the effect of calcium chloride (CaCl2) added
116 ork, three Spanish local varieties of Prunus avium (L.), as well as two foreign varieties were studie
117 f red-fleshed sweet cherry cultivars (Prunus avium; Lapins, Stella, Sweetheart and Staccato), with di
118                                Mycobacterium avium (M. avium) subspecies vary widely in both pathogen
119 ma gondii (T. gondii, tg), and Mycobacterium avium (M. avium, ma) are the principal causes of morbidi
120 from 12 NTM-PD patients due to Mycobacterium avium, M. intracellulare, M. abscessus, or M. massiliens
121 repeatedly positive for NTMs, the species M. avium, M. mucogenicum, and Mycobacterium abscessus were
122  better understand the role of Mycobacterium avium-M. intracellulare complex isolates in human diseas
123                        The 159 Mycobacterium avium-M. intracellulare complex isolates were further id
124  Additional differentiation of Mycobacterium avium-M. intracellulare complex strains into M. avium an
125 (T. gondii, tg), and Mycobacterium avium (M. avium, ma) are the principal causes of morbidity and mor
126                                           M. avium mmpL4 proteins were found to bind to VDAC-1 protei
127 fferent mycobacterial strains (Mycobacterium avium, Mycobacterium bovis BCG or Mtb), were exposed to
128 6S rRNA gene A1408G mutation and included M. avium, Mycobacterium intracellulare, and Mycobacterium c
129  spp., Legionella pneumophila, Mycobacterium avium, Mycobacterium intracellulare, Pseudmonas aerugino
130                                Mycobacterium avium, Mycobacterium tuberculosis, and Mycobacterium kan
131 d to the species level by MycoID as being M. avium (n = 98; 61.1%), M. intracellulare (n = 57; 35.8%)
132                    To investigate whether M. avium needs to attach to the internal surface of the vac
133 . intracellulare probes), and 3 (7%) were M. avium; none were M. intracellulare.
134                                           M. avium or M. tuberculosis infection was markedly increase
135       Later, the mice received Mycobacterium avium or Mycobacterium tuberculosis I.T.
136 mus following dissemination of Mycobacterium avium or Mycobacterium tuberculosis.
137 obial VOCs and (2) apply it to Mycobacterium avium paratuberculosis; the vaccine strain of M. bovis B
138            When tested against Mycobacterium avium, PCIH was more effective than INH at inhibiting ba
139 ructural genomics protein from Mycobacterium avium (PDB ID 3q1t) has been reported to be an enoyl-CoA
140 M. intracellulare, Acanthamoeba spp., and M. avium peaked during the dry season.
141 d down for MR expression showed increased M. avium phagosome-lysosome fusion relative to control cell
142 of cross-reactivity with the M. avium subsp. avium proteins that was higher than the degree of cross-
143 annels in the transport of known secreted M. avium proteins, we demonstrated that the porin channels
144 n = 238, 92.6%), followed by M. avium subsp. avium serotype 1 (n = 12, 4.7%) and serotype 2, 3 (n = 7
145 is; the bird type, including M. avium subsp. avium serotype 1 and serotype 2, 3 (also M. avium subsp.
146 , a major surface component of Mycobacterium avium, showed limited acidification and delayed recruitm
147 distribution in Great Britain, Mycobacterium avium ssp. paratuberculosis (MAP) was detected in 115 of
148 . casei, M. tuberculosis H37Ra, and three M. avium strains and for cytotoxic activity against seven d
149       We determined the subspecies of 257 M. avium strains isolated from patients at the M.D. Anderso
150 of inflammatory cytokines by host-adapted M. avium strains.
151                                Mycobacterium avium subsp hominissuis is associated with infection of
152 Johnes disease (JD), caused by Mycobacterium avium subsp paratuberculosis (MAP), occurs worldwide as
153 e (n = 3) and cattle infected with either M. avium subsp. avium and Mycobacterium bovis were exposed
154 ted a degree of cross-reactivity with the M. avium subsp. avium proteins that was higher than the deg
155 most common (n = 238, 92.6%), followed by M. avium subsp. avium serotype 1 (n = 12, 4.7%) and serotyp
156 sp. hominissuis; the bird type, including M. avium subsp. avium serotype 1 and serotype 2, 3 (also M.
157  very similar to yet distinguishable from M. avium subsp. avium.
158                                Mycobacterium avium subsp. hominissuis (MAH) is increasingly recognize
159 lls (which have been shown to induce anti-M. avium subsp. hominissuis activity when added to THP-1 ce
160 ng that MBP-1 expression is important for M. avium subsp. hominissuis adherence to the host cell.
161  facilitates an improved understanding of M. avium subsp. hominissuis and how it establishes infectio
162 ar phagocytes cocultured with established M. avium subsp. hominissuis biofilm and surveyed various as
163       Our data collectively indicate that M. avium subsp. hominissuis biofilm induces TNF-alpha-drive
164                  The reasoning behind how M. avium subsp. hominissuis biofilm is allowed to establish
165 g) assay determined that contact with the M. avium subsp. hominissuis biofilm led to early, widesprea
166                                           M. avium subsp. hominissuis biofilm triggered robust tumor
167 ring initial colonization of the airways, M. avium subsp. hominissuis forms microaggregates composed
168 no efficient approach to prevent or treat M. avium subsp. hominissuis infection in the lungs.
169 BP-1 immune serum significantly inhibited M. avium subsp. hominissuis infection throughout the respir
170 s not seen until much later in planktonic M. avium subsp. hominissuis infection.
171                                Mycobacterium avium subsp. hominissuis is an opportunistic human patho
172                We therefore conclude that M. avium subsp. hominissuis is the dominant M. avium subspe
173                            Results showed M. avium subsp. hominissuis to be most common (n = 238, 92.
174 erizes a pathogenic mechanism utilized by M. avium subsp. hominissuis to bind and invade the host res
175                               "Mycobacterium avium subsp. hominissuis" is a robust and pervasive envi
176                               "Mycobacterium avium subsp. hominissuis" is an opportunistic environmen
177 d to THP-1 cells infected with planktonic M. avium subsp. hominissuis).
178                  Of the 238 patients with M. avium subsp. hominissuis, 65 (27.3%) showed evidence of
179 um subsp. paratuberculosis and Mycobacterium avium subsp. hominissuis, a pathogen known to interact w
180 ptosis but did not lead to elimination of M. avium subsp. hominissuis.
181 teins exposed at the bacterial surface of M. avium subsp. hominissuis.
182 racterize the surface-exposed proteome of M. avium subsp. hominissuis.
183 ntly less efficient at dissemination than M. avium subsp. hominissuis.
184 f three types: the human or porcine type, M. avium subsp. hominissuis; the bird type, including M. av
185 f Ag85A, Ag85B, and Ag85C from Mycobacterium avium subsp. paratuberculosis (MAP) (K(D) values were de
186 optimized for the isolation of Mycobacterium avium subsp. paratuberculosis (MAP) from milk and colost
187 vailable diagnostic assays for Mycobacterium avium subsp. paratuberculosis (MAP) have poor sensitivit
188 inflammatory disease caused by Mycobacterium avium subsp. paratuberculosis (MAP) in cattle and other
189   Johne's disease is caused by Mycobacterium avium subsp. paratuberculosis (MAP) infection and result
190 echanisms of host responses to Mycobacterium avium subsp. paratuberculosis (MAP) infection during the
191 ate the stochastic dynamics of Mycobacterium avium subsp. paratuberculosis (MAP) infection on US dair
192 solates with the sequenced bovine isolate M. avium subsp. paratuberculosis (MAP) K-10.
193                      Total lipids from an M. avium subsp. paratuberculosis (Map) ovine strain (S-type
194 cterium kansasii (n = 10), and Mycobacterium avium subsp. paratuberculosis (n = 10), cases exposed to
195 ll as cattle experimentally infected with M. avium subsp. paratuberculosis (n = 3) were used to probe
196                          We now know that M. avium subsp. paratuberculosis activates the epithelial l
197  The invasion of the intestinal mucosa by M. avium subsp. paratuberculosis and Mycobacterium avium su
198 ity, and oxidative stress were similar in M. avium subsp. paratuberculosis and Mycobacterium tubercul
199 ncluded were previously reported or known M. avium subsp. paratuberculosis antigens to serve as a fra
200    Monitoring cellular markers, only live M. avium subsp. paratuberculosis bacilli were able to preve
201 e's disease, allowing the transmission of M. avium subsp. paratuberculosis between animals.
202 ted for the presence of viable Mycobacterium avium subsp. paratuberculosis by a novel peptide-mediate
203 cols to ensure that low concentrations of M. avium subsp. paratuberculosis can be detected.
204                                Mycobacterium avium subsp. paratuberculosis causes an enteric infectio
205                                Mycobacterium avium subsp. paratuberculosis causes Johne's disease in
206                 Infection with Mycobacterium avium subsp. paratuberculosis causes Johne's disease in
207                                Mycobacterium avium subsp. paratuberculosis causes Johne's disease, an
208  resulted in a greater recovery of viable M. avium subsp. paratuberculosis cells from milk than from
209 reatment decreased the recovery of viable M. avium subsp. paratuberculosis cells more than treatment
210                          Counts of viable M. avium subsp. paratuberculosis cells ranging from 1 to 11
211                        We interrogated an M. avium subsp. paratuberculosis DeltasigL mutant against a
212 ociated with transcriptional responses of M. avium subsp. paratuberculosis during macrophage infectio
213 's patches, were used to demonstrate that M. avium subsp. paratuberculosis enters the intestinal muco
214 chnique, we found 15 different strains of M. avium subsp. paratuberculosis from a total of 142 isolat
215  the three evaluated for the isolation of M. avium subsp. paratuberculosis from milk, as it achieved
216                               To identify M. avium subsp. paratuberculosis genes associated with the
217    On the transcriptional level, over 300 M. avium subsp. paratuberculosis genes were significantly a
218   In addition, the results indicated that M. avium subsp. paratuberculosis had equal abilities to cro
219                      We hypothesized that M. avium subsp. paratuberculosis harnesses host responses t
220       The infection biology of Mycobacterium avium subsp. paratuberculosis has recently crystallized,
221 actions between epithelium and Mycobacterium avium subsp. paratuberculosis have not been intensively
222 n optimized protocol for the isolation of M. avium subsp. paratuberculosis in milk.
223                              We show that M. avium subsp. paratuberculosis infection led to phagosome
224                                Mycobacterium avium subsp. paratuberculosis infection of cattle takes
225  sigL in the pathogenesis and immunity of M. avium subsp. paratuberculosis infection, a potential rol
226 ination of immune responses occurs during M. avium subsp. paratuberculosis infection, with these resp
227  were culture positive, indicating a true M. avium subsp. paratuberculosis infection.
228   A number of studies have suggested that M. avium subsp. paratuberculosis interacts with M cells in
229                               In summary, M. avium subsp. paratuberculosis interacts with the intesti
230 steps to further elucidate the process of M. avium subsp. paratuberculosis invasion.
231                                     Thus, M. avium subsp. paratuberculosis is an opportunist that tak
232                     Once inside the cell, M. avium subsp. paratuberculosis is known to survive harsh
233                                Mycobacterium avium subsp. paratuberculosis is shed into the milk and
234                                           M. avium subsp. paratuberculosis isolates from bovine fecal
235  of the genetic relatedness of Mycobacterium avium subsp. paratuberculosis isolates harvested from bo
236                                       The M. avium subsp. paratuberculosis isolates were obtained fro
237 on scheme (tissue-associated versus fecal M. avium subsp. paratuberculosis isolates).
238 rase recognition in the tissue-associated M. avium subsp. paratuberculosis isolates.
239    In this report, the stress response of M. avium subsp. paratuberculosis on a genome-wide level (st
240 ulated with 10(2) to 10(8) CFU/ml of live M. avium subsp. paratuberculosis organisms.
241           To improve our understanding of M. avium subsp. paratuberculosis pathogenesis, we examined
242 ter decipher the role of sigma factors in M. avium subsp. paratuberculosis pathogenesis, we targeted
243 is that it enables a direct comparison of M. avium subsp. paratuberculosis proteins to each other in
244     Infection of the host with Mycobacterium avium subsp. paratuberculosis results in chronic and pro
245 ogical significance of such regulators in M. avium subsp. paratuberculosis rremains elusive.
246                            The results of M. avium subsp. paratuberculosis strain typing and observed
247 e media determined differential growth of M. avium subsp. paratuberculosis strains and that this shou
248 nt methods on the selection of Mycobacterium avium subsp. paratuberculosis subtypes.
249 (sigH) that was shown to be important for M. avium subsp. paratuberculosis survival inside gamma inte
250 low-shedding cows are truly infected with M. avium subsp. paratuberculosis than are passively sheddin
251 ted macrophage recruitment in response to M. avium subsp. paratuberculosis using a MAC-T bovine macro
252  suggested a substantial role for sigL in M. avium subsp. paratuberculosis virulence, as indicated by
253 tal strain, suggesting a role for sigH in M. avium subsp. paratuberculosis virulence.
254                                           M. avium subsp. paratuberculosis was also shown to interact
255                                           M. avium subsp. paratuberculosis was capable of invading th
256               To our surprise, strains of M. avium subsp. paratuberculosis were able to traverse the
257                             No strains of M. avium subsp. paratuberculosis were found.
258 cows that were low shedders of Mycobacterium avium subsp. paratuberculosis were passively shedding or
259 pon translocation, dendritic cells ingest M. avium subsp. paratuberculosis, but this process does not
260                                Mycobacterium avium subsp. paratuberculosis, the agent of Johne's dise
261 tion of the cell communication pathway by M. avium subsp. paratuberculosis, which loosens the integri
262 tigated whether it is possible that these M. avium subsp. paratuberculosis-infected animals could hav
263 o seroreactivity against M. kansasii- and M. avium subsp. paratuberculosis-infected animals.
264 5 to 2.0% did not affect the viability of M. avium subsp. paratuberculosis.
265 een infected by environmental exposure of M. avium subsp. paratuberculosis.
266 atuberculosis than are passively shedding M. avium subsp. paratuberculosis.
267 passively shedding or truly infected with M. avium subsp. paratuberculosis.
268 ication of previously unknown antigens of M. avium subsp. paratuberculosis.
269 ubsp. silvaticum); and the ruminant type, M. avium subsp. paratuberculosis.
270                   Shedding levels (CFU of M. avium subsp. paratuberculosis/g of feces) for the animal
271                                           M. avium subsp. silvaticum isolates were observed to have a
272  avium serotype 1 and serotype 2, 3 (also M. avium subsp. silvaticum); and the ruminant type, M. aviu
273                       Genome diversity in M. avium subspecies appears to be mediated by large sequenc
274  avium subsp. hominissuis is the dominant M. avium subspecies clinically, that the two bird-type subs
275 entify large sequence polymorphisms among M. avium subspecies obtained from a variety of host animals
276 ed by slow replicating bacilli Mycobacterium avium subspecies paratuberculosis (MAP) infecting macrop
277                   In a prospective study, M. avium subspecies paratuberculosis detection in early Cro
278     By the analysis of 14 SNPs Mycobacterium avium subspecies paratuberculosis isolates can be charac
279  genome sequence data from 133 Mycobacterium avium subspecies paratuberculosis isolates with differen
280 e large-scale global typing of Mycobacterium avium subspecies paratuberculosis isolates.
281 oA carboxylase holoenzyme from Mycobacterium avium subspecies paratuberculosis revealed an architectu
282                      Typing of Mycobacterium avium subspecies paratuberculosis strains presents a cha
283  bp fragment of genomic DNA of Mycobacterium avium subspecies paratuberculosis through real-time PCR
284 intestinal pathogens including Mycobacterium avium subspecies paratuberculosis, adherent-invasive Esc
285 es for the characterization of Mycobacterium avium subspecies paratuberculosis, and whole-genome sequ
286 uberculosis are both caused by Mycobacterium avium subspecies paratuberculosis.
287 5P), yet both lipids are present in other M. avium subspecies.
288                      Mycobacterium avium (M. avium) subspecies vary widely in both pathogenicity and
289  or siRNA lead to significant decrease of M. avium survival.
290 n the cytoplasm of HEp-2 cells exposed to M. avium, the recombinant protein was shown to be potential
291  within a single subspecies of Mycobacterium avium these lipids can differ.
292 rial uptake by macrophages, we screened a M. avium transposon mutant library for the inability to ent
293 s (VDAC) were identified as components of M. avium vacuoles in macrophages.
294 bed in macrophages infected by Mycobacterium avium was not observed in our model, which presented a d
295                          While Mycobacterium avium was once regarded as innocuous, its high frequency
296                            In comparison, M. avium was recovered from 141 water/biofilm samples.
297                                           M. avium was recovered more frequently from sterile sites t
298   Subspecies and host adapted isolates of M. avium were distinguishable by the presence or absence of
299 ized the six SDSs, but L. pneumophila and M. avium were not detected.
300 athogens Toxoplasma gondii and Mycobacterium avium when administered via the i.p. or i.v. route, resp
301 rlying thymic atrophy during infection by M. avium with the participation of locally produced NO, end

 
Page Top